Emory University;U.S. Government represented by the United States Department of Veterans Affairs
发明人:
Shanthi Srinivasan
申请号:
US16037268
公开号:
US20180326009A1
申请日:
2018.07.17
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The disclosure relates to therapeutic methods for regulating weight gain, metabolic syndrome, and insulin resistance. In certain embodiments, the disclosure relates to methods of treating or preventing obesity, metabolic syndrome, or insulin resistance by administering an effective amount of a pharmaceutical composition comprising one or more GDNF receptor agonists to a subject in need thereof.